Cited by 207Microbial Metabolites in Food BiotechnologyAdipokines, Inflammation, and Metabolic DiseasesNatural Antidiabetic Agents Studies

Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial

Dehghan, Parvin, Pourghassem Gargari, Bahram, Asghari Jafar-abadi, Mohammad·2014·Nutrition

Abstract

Objectives Anti-inflammatory therapeutic approaches are considered for the management of type 2 diabetes and for the prevention of its complications. There is limited evidence regarding the effects of prebiotics on inflammation, especially in patients with type 2 diabetes. This trial aims to examine the effects of oligofructose-enriched inulin on glycemic status, inflammation markers, and metabolic endotoxemia in female patients.Methods Over a period of 8 wk, 52 women with body mass indices of >25 kg/m(2) but <35 kg/m(2) with type 2 diabetes were randomly assigned to either an intervention group, in which participants were given oligofructose-enriched inulin (n = 27, consuming 10 g/d of oligofructose-enriched inulin), or to a control group, in which participants were given maltodextrin (n = 25, consuming 10 g/d of maltodextrin). Fasting plasma glucose, glycosylated hemoglobin, high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-α, interferon-γ, interleukin-10, and plasma lipopolysaccharide were measured before and after the intervention. Data were analyzed with the use of SPSS software version 13. Paired and unpaired Student t tests and analysis of covariance were used to compare quantitative variables.Results Oligofructose-enriched inulin caused a significant decrease in the levels of fasting plasma glucose (19.2 mg/dL; 9.50%), glycosylated hemoglobin (1.0%; 8.40%), interleukin-6 (1.3 pg/mL; 8.15%), tumor necrosis factor-α (3.0 pg/mL; 19.80%) and plasma lipopolysaccharide (6.0 EU/mL; 21.95%) as compared with maltodextrin (P < 0.05). Decreases in levels of interferon-γ (0.3 pg/mL; 16.50%) and high-sensitivity C-reactive protein (3.9 ng/mL; 31.70%) and an increase in the level of interleukin-10 (0.4 pg/mL, 11.50%) were not significant in the oligofructose-enriched inulin group as compared with the maltodextrin group.Conclusions In women with type 2 diabetes and suboptimal daily dietary fiber intake, oligofructose-enriched inulin may help to modulate some inflammatory markers.

Integrity signals

Registry

Crossref · 10.1016/j.nut.2013.09.005

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dehghan, P., Pourghassem Gargari, B., & Asghari Jafar-abadi, M.
Affiliations
Tabriz University of Medical Sciences (IR)
Venue
Nutrition
Publisher
Elsevier BV
Published
2014-04
Volume
30
Issue
4
Pages
418-423
ISSN
0899-9007 (ISSN-L)
OpenAlex
W1977968392
Cited by
207
References
43
Citations by year
2026: 5 · 2025: 22 · 2024: 18 · 2023: 12 · 2022: 38 · 2021: 13 · 2020: 14 · 2019: 25 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 4
FWCI
9.87
Type
journal article
Language
en
Open access
closed
Locations
  • Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
University of Tabriz
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
oligofructose-enriched inulin, prebiotics, type 2 diabetes, women, inflammatory markers, endotoxemia, lipopolysaccharide, glycemic control, HbA1c, fasting blood glucose, interleukin-6, TNF-α, C-reactive protein, IL-10, interferon-gamma
MeSH terms
Adult, Blood Glucose, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Inflammation, Interferon-gamma, Inulin, Lipopolysaccharides, Middle Aged, Oligosaccharides, Tumor Necrosis Factor-alpha, Biomarkers, Interleukin-6, Body Mass Index, Endotoxemia, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review